Tilray

$22.46
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.83 (+3.84%) As of 7:44 PM UTC today

Why Robinhood?

You can buy or sell Tilray and other stocks, options, and ETFs commission-free!

About TLRY

Tilray, Inc. engages in the research, cultivation, production, and distribution of medical cannabis and cannabinoids. The Company is focused on medical cannabis research, cultivation, processing and distribution of cannabis products worldwide. Its products include dried cannabis and cannabis extracts. It operates through the following segments: Cannabis and Hemp. The Cannabis segment sales consists of adult-use, medical and bulk sales of cannabis under regulated licenses and sold to retail, wholesale, pharmacy, government, and direct to patient. The Hemp segment sales consist of hemp seed, hemp foods, board spectrum hemp extract containing CBD which are sold in an unlicensed operation and sold to retail, wholesale and direct to consumers. The company was founded on January 24, 2018 and is headquartered in Nanaimo, Canada. The listed name for TLRY is Tilray, Inc. Class 2 Common Stock.

CEO
Brendan Kennedy
Employees
1,030
Headquarters
Nanaimo, British Columbia
Founded
2018
Market Cap
4.27B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
27.78M
High Today
$23.42
Low Today
$20.80
Open Price
$21.72
Volume
13.67M
52 Week High
$67.00
52 Week Low
$2.43

TLRY News

MarketWatchMar 5

Tilray Inc. Cl 2 stock falls Friday, underperforms market

Shares of Tilray Inc. Cl 2 TLRY, -4.50% slipped 4.50% to $21.63 Friday, on what proved to be an all-around positive trading session for the stock market, with t
CNBCMar 5

Cannabis stocks slump for second straight week as prospects dim for nationwide legalization

A worker inspects cannabis plants inside the grow room at the Aphria Inc. Diamond facility in Leamington, Ontario, Canada, on Wednesday, Jan. 13, 2021. Tilray I

TLRY Earnings

-$1.45
-$0.97
-$0.48
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 10, After Hours

You May Also Like

CVI
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure